The rise of a grey market in India, where unsupervised doses are sold at exorbitant rates, demonstrates that excessive ...

Two groups are fighting for an edge in one of the most lucrative drug classes in the pharmaceutical industry’s history.

New drugs targeting weight loss and diabetes management such as Ozempic/Wegovy can help lower the number of young people impacted by type 2 diabetes, a paediatrician says. Diabete ...

Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.

Trump team is negotiating with weight-loss drug makers to lower prices to $149 a month: report - Obesity drugs have become an ...

Two years later, those treatments have thrust Metsera to the centre of a fierce takeover battle, with Ozempic maker Novo Nordisk and Pfizer willing to pay up to $10bn for the company. Both once again ...

People looking to lose weight and lower their blood sugar may someday be able to get a single injection that turns their ...